Disparities in DMT treatment: Demographic and neurocognitive differences between MS patients currently treated versus not treated with disease-modifying therapies

Leavitt, V. M., Dworkin, J. D., Galioto, R., & Ratzan, A. S. (2024). Disparities in DMT treatment: Demographic and neurocognitive differences between MS patients currently treated versus not treated with disease-modifying therapies. Multiple Sclerosis and Related Disorders, 85, 105508. https://doi.org/10.1016/j.msard.2024.105508
Authors:
Victoria M Leavitt
Jordan D Dworkin
Rachel Galioto
Alexander S Ratzan
Affiliated Authors:
Victoria M Leavitt
Jordan D Dworkin
Alexander S Ratzan
Columbia Affiliation:
Subjects:
Multiple Sclerosis (MeSH)
Educational Status (MeSH)
Author Keywords:
disease modifying therapy
disparities
cognition
sex differences
multiple sclerosis
elink
Publication Type:
Article
Unique ID:
10.1016/j.msard.2024.105508
PMID:
38452646
DOI:
10.1016/j.msard.2024.105508
Journal:
Multiple Sclerosis and Related Disorders
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: